Manipulation of cGMP levels and activation of PKG by activating ANP and receptors signals represent a potential therapeutic strategy to enhance regrowth of SGN neurites and support SGN survival, which promises to be a fruitful area for developing new and effective therapies for SNHL. Here, NPPA is linked to sensorineural hearing loss disorder.